BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 7792436)

  • 1. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
    Puchelle E; de Bentzmann S; Zahm JM
    Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of mucus secretion and ion transport in airways.
    Nadel JA; Davis B; Phipps RJ
    Annu Rev Physiol; 1979; 41():369-81. PubMed ID: 373597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of cystic fibrosis airway mucus transportability by recombinant human DNase is related to changes in phospholipid profile.
    Zahm JM; Galabert C; Chaffin A; Chazalette JP; Grosskopf C; Puchelle E
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1779-84. PubMed ID: 9620905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of rhDNase on rheologic properties and transport capacity of mucus in cystic fibrosis].
    Puchelle E; Zahm JM
    Arch Pediatr; 1995 Jul; 2(7):670-3. PubMed ID: 7663658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiology of airway mucus clearance.
    Rubin BK
    Respir Care; 2002 Jul; 47(7):761-8. PubMed ID: 12088546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the physiochemical properties of mucus in the protection of the respiratory epithelium.
    Girod S; Zahm JM; Plotkowski C; Beck G; Puchelle E
    Eur Respir J; 1992 Apr; 5(4):477-87. PubMed ID: 1563506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucus structure and properties in cystic fibrosis.
    Rubin BK
    Paediatr Respir Rev; 2007 Mar; 8(1):4-7. PubMed ID: 17419972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheological and transport properties of airway secretions in cystic fibrosis--relationships with the degree of infection and severity of the disease.
    Puchelle E; Jacquot J; Beck G; Zahm JM; Galabert C
    Eur J Clin Invest; 1985 Dec; 15(6):389-94. PubMed ID: 3938409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent in vitro effect of recombinant human DNase on rheological and transport properties of cystic fibrosis respiratory mucus.
    Zahm JM; Girod de Bentzmann S; Deneuville E; Perrot-Minnot C; Dabadie A; Pennaforte F; Roussey M; Shak S; Puchelle E
    Eur Respir J; 1995 Mar; 8(3):381-6. PubMed ID: 7789481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
    Feng W; Garrett H; Speert DP; King M
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rhDNase on purulent airway secretions in chronic bronchitis.
    Puchelle E; Zahm JM; de Bentzmann S; Grosskopf C; Shak S; Mougel D; Polu JM
    Eur Respir J; 1996 Apr; 9(4):765-9. PubMed ID: 8726943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis and other respiratory diseases of impaired mucus clearance.
    Livraghi A; Randell SH
    Toxicol Pathol; 2007 Jan; 35(1):116-29. PubMed ID: 17325980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia.
    Tarran R; Trout L; Donaldson SH; Boucher RC
    J Gen Physiol; 2006 May; 127(5):591-604. PubMed ID: 16636206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperviscous airway periciliary and mucous liquid layers in cystic fibrosis measured by confocal fluorescence photobleaching.
    Derichs N; Jin BJ; Song Y; Finkbeiner WE; Verkman AS
    FASEB J; 2011 Jul; 25(7):2325-32. PubMed ID: 21427214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic aerosols and airway secretions.
    Rubin BK
    J Aerosol Med; 1996; 9(1):123-30. PubMed ID: 10160202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucoviscidosis: what is the cause of bronchitis?].
    Bellon G; Gilly R
    Pediatrie; 1988; 43(1):5-10. PubMed ID: 2455268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
    Miyata T
    Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Airway mucus in cystic fibrosis.
    Puchelle E; Bajolet O; Abély M
    Paediatr Respir Rev; 2002 Jun; 3(2):115-9. PubMed ID: 12297057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.